Viewing data from:

IVERMECTIN

ANDA

IVERMECTIN | A215210 | ZYDUS LIFESCIENCES GLOBAL FZE

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: SOOLANTRA(TE code: AB)

Citizen Petitions

1 petition (1 open) from Regulations.gov

Petition	Type	Filed	Status	Petitioner
Suitability Petition from Argenta FDA-2026-P-6705 · 4 docket documents Argenta filed a Suitability Petition under section 512(n)(3) of the Federal Food, Drug, and Cosmetic Act requesting that the FDA declare ivermectin 1.87% oral liquid suitable for submission in an Abbreviated New Animal Drug Application (ANADA) for horses, with the reference listed new animal drug be	Suitability	2026-06-11	Open	Argenta

Source: Regulations.gov. FDA citizen petitions matched by application number.

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 1 NDC

Highest NADAC/Unit

$3.08

per gm

Lowest NADAC/Unit

$3.08

per gm

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
72578012008IVERMECTIN 1% CREAM	$3.08	GM	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain4 active DMFs3 inactive

4 active API suppliers hold Drug Master Files for this ingredient.

HOVIONE PHARMASCIENCE LTDIVERMECTIN USP

DMF 213952008

ZHEJIANG HISUN PHARMACEUTICAL CO LTDIVERMECTIN USP

DMF 216242008

INDUSTRIALE CHIMICA SRLIVERMECTIN PH. FUR.

DMF 364942021

HEBEI MEIHE PHARMACEUTICAL CO LTDIVERMECTIN

DMF 385532023

HAIMEN PHARMACEUTICAL FACTORYInactiveIVERMECTIN, NON-STERILE BULK DRUG

DMF 127551997

SHANGHAI TONGREN PHARMACEUTICAL CO LTDInactiveIVERMECTIN

DMF 130371998

DELTA TECH LTDInactiveIVERMECTIN

DMF 176732004

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 1%

0 patents0 exclusivities▴

CREAM;TOPICAL | Approved: Aug 2, 2022

No patent or exclusivity listings for this strength.